The de-extinction startup is looking to double or triple its previous valuation, according to the report.
In Brief
Posted:
4:39 PM PDT · July 20, 2026
Image Credits:Colossal / Colossal Biosciences
When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy surrounding the project, the company was building valuable technologies that justify its $10.2 billion valuation.
Colossal hasn't revived a single extinct species, yet Colossal is reportedly in talks at a $20 billion to $30 billion valuation.
Tech entrepreneur Ben Lamm is spearheading Colossal Biosciences, a company aiming to bring back extinct species like the woolly…
A few years ago, the idea of reviving extinct animals sat closer to speculative science fiction than anything investors would…
The bioscience startup has attracted billions in investment – and a flurry of criticism, but founder tells the Guardian plans to…
Colossal Biosciences’ CEO says its work follows a ‘moral obligation’ while critics say it’s ‘tech bro’ hype that could undermine…
Colossal Biosciences CEO Ben Lamm explains how ancient DNA, AI and CRISPR are helping scientists pursue de-extinction.
